Tela Bio Company Insiders

Tela Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.3868) % which means that it has lost $0.3868 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.7641) %, meaning that it created substantial loss on money invested by shareholders. Tela Bio's management efficiency ratios could be used to measure how well Tela Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of February 20, 2026, Return On Tangible Assets is expected to decline to -0.42. In addition to that, Return On Capital Employed is expected to decline to -0.45. At present, Tela Bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 11.2 M, whereas Total Assets are forecasted to decline to about 67.8 M. As of February 20, 2026, Common Stock Shares Outstanding is expected to decline to about 16.4 M. In addition to that, Net Loss is expected to decline to about (41.9 M)Tela Bio shows a total of 44.53 Million outstanding shares. The majority of Tela Bio outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Tela Bio to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Tela Bio. Please pay attention to any change in the institutional holdings of Tela Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Tela Bio in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Tela Bio, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Tela Bio Workforce Comparison

Tela Bio Profit Margins

The company has Profit Margin (PM) of (0.51) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.37) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.37.

Tela Bio Insider Trading

Tela Bio Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Tela Bio often depends on how effective the management is. Tela Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tela management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tela management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Tela Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tela Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Tela Bio's management manipulating its earnings.

When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.